Follow on Google News News By Tag Industry News News By Place Country(s) Industry News
Follow on Google News | Global Hepatitis C Drugs Market would be US$ 5.9 Billion by 2025 | Renub ResearchThe hepatitis C drugs market will also propel due to initiative taken by governments and NGOs around the world by raising awareness and educating people to challenge hepatitis C infection.
By: Renub Research Causes of this infection are unsterilized medical equipment, blood transfusion from infected mother to newborn baby and sharing needles. Countries like India, China and Brazil will be the major market as compared to the market in developed countries. The hepatitis C drugs market will also propel due to initiative taken by governments and NGOs around the world by raising awareness and educating people to challenge hepatitis C infection. COVID-19 Impact on Hepatitis C Drug Market Treatment of COVID-19 patients is the prime focus of healthcare facilities, and other patients are unable to get treated properly. Telehealth has become a trend during this period as most of the health experts are providing consultation through this system. Governments around the world are investing hugely in health systems to fight against COVID-19. These initiatives will be beneficial in the long term; after this pandemic, medical experts will focus on the development of vaccine and drugs for other diseases like Hepatitis C as well. About Company: Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to- Contact Us: Renub Research Phone No: +1 678-302-0700 (USA) | +91-120-421- Email: info@renub.com Web: https://www.renub.com Follow the Link for Report Customization: End
Account Email Address Account Phone Number Disclaimer Report Abuse
|
|